Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15%

Medical technology company Becton, Dickinson and Company (NYSE: BDX) reported a decline in adjusted earnings for the first quarter of fiscal 2026.

• On an adjusted basis, Q1 earnings declined to $2.91 per share from $3.43 per share in Q1 2025
• First-quarter revenues increased 1.6% YoY to $5.3 billion; revenues rose 0.4% on a currency-adjusted basis
• Revenues in the US and International markets grew 2.6% and 0.2%, respectively
• Unadjusted earnings per share rose to $1.34 in the December quarter from $1.04 per share last year
• Net income for the quarter was $382 million, vs. $303 million in the corresponding quarter a year earlier
• For fiscal 2026, management expects revenue to increase in low-single-digit plus from the prior year
• On a currency-adjusted basis, full-year revenue is expected to grow in low-single-digit
• The guidance for FY26 adjusted earnings per share is between $12.35 and $12.65